Cycle 7: NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)

Sponsor: National Institute of Neurological Disorders and Stroke
Due Date: July 18, 2017 by 5 pm local time of applicant
Award: Budgets are not limited but have to reflect the actual needs of the proposed project. UH2 phase should rarely exceed 1M per year and UH3 phase should rarely exceed 1.5M per year.